Primary and booster vaccination in reducing severe clinical outcomes associated with Omicron Naïve infection-Reference-Cited by-同舟云学术

Primary and booster vaccination in reducing severe clinical outcomes associated with Omicron Naïve infection

Published:2023-01 Issue:1 Volume:16 Page:55-63
ISSN:1876-0341
Container-title:Journal of Infection and Public Health
language:en
Short-container-title:Journal of Infection and Public Health

Author:

Hsu Chen-Yang^ORCID,Chang Jung-Chen^ORCID,Chen Sam Li-Shen,Chang Hao-Hsiang^ORCID,Lin Abbie Ting-Yu,Yen Amy Ming-Feng^ORCID,Chen Hsiu-Hsi^ORCID

Funder

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Reference49 articles.

1. The changing epidemiology of SARS-CoV-2;Koelle;Science,2022

2. Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022;Castillo;Eurosurveillance,2022

3. Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant;Andrews;N Engl J Med,2022

4. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis;Ssentongo;BMC Infect Dis,2022

5. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into three trajectories of omicron-related all-cause death reduced by COVID-19 booster vaccination;Journal of Infection and Public Health;2024-05

2. Kinetics of Viral Shedding for Outbreak Surveillance of Emerging Infectious Disease: A Modelling Approach to SARS-CoV-2 Alpha and Omicron Infection (Preprint);JMIR Public Health and Surveillance;2023-11-25

3. Kinetics of Viral Shedding for Outbreak Surveillance of Emerging Infectious Disease: A Modelling Approach to SARS-CoV-2 Alpha and Omicron Infection (Preprint);2023-11-25

4. Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case–Control Study Based on the French National Health Data System;Open Forum Infectious Diseases;2023-09-08